{"doi":"10.24292/01.mf.0418.7","title":"Why do I use ivabradine in my patients?","abstract":null,"journal":"Medycyna Faktów","year":2018,"id":661971,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1358166,"name":"Alicja Nowak","orcid":null,"position":1,"is_corresponding":false},{"id":1728132,"name":"Ewa Straburzyńska-Migaj","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Why do I use ivabradine in my patients?","abstract":"Ivabradine inhibits sinus node IF channels and lowers the heart rate. It is used in patients with sinus rhytm and heart rate of ≥70/min, who despite the optimal treatment failed to achieve the correct one. In the trials, ivabradine significantly reduced the mortality due to heart failure (26%, p = 0.014) and the risk of hospitalization due to exacerbation of heart failure (18%). Due to neutral influence on hemodynamic parameters and inotropic effects, ivabradine can be administered in patients with elevated heart rate who do not achieve the target dose of β-blockers. Despite the undoubted benefits and clear ESC recommendations, ivabradine is still used in too few patients with HFrEF.","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19162232","pmcid":null,"openalex_id":"https://openalex.org/W2914770446","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.31266479,"influential_citations":0,"citation_trend":[],"oa_status":"gold","license":null,"oa_locations":[{"url":"https://doi.org/10.24292/01.mf.0418.7","host_type":"journal"},{"url":"https://doi.org/10.24292/01.mf.0418.7","host_type":"publisher"}],"fields_of_study":["Heart rate and cardiovascular health"],"mesh_terms":[],"keywords":["Ivabradine","Heart failure","Medicine","Inotrope","Exacerbation","Heart rate","Cardiology","Internal medicine","RESTING HEART RATE","Hemodynamics","Bradycardia","Anesthesia","Blood pressure"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-12T12:07:15.849425Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}